ID: ALA5281095

Max Phase: Preclinical

Molecular Formula: C18H20O4

Molecular Weight: 300.35

Associated Items:

Representations

Canonical SMILES:  CC1(C)c2cc(O)c(O)cc2-c2cc(O)c(O)cc2C1(C)C

Standard InChI:  InChI=1S/C18H20O4/c1-17(2)11-7-15(21)13(19)5-9(11)10-6-14(20)16(22)8-12(10)18(17,3)4/h5-8,19-22H,1-4H3

Standard InChI Key:  MVTHHGDJXDXEMT-UHFFFAOYSA-N

Associated Targets(Human)

Alpha-synuclein 10960 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 300.35Molecular Weight (Monoisotopic): 300.1362AlogP: 3.74#Rotatable Bonds: 0
Polar Surface Area: 80.92Molecular Species: NEUTRALHBA: 4HBD: 4
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.02CX Basic pKa: CX LogP: 4.14CX LogD: 4.13
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.56Np Likeness Score: 0.80

References

1. Bernardes G, Munir O, Krol ES..  (2023)  The effect of diphenylethane side-chain substituents on dibenzocyclohexadiene formation and their inhibition of α-synuclein aggregation in vitro.,  78  [PMID:36587551] [10.1016/j.bmc.2022.117147]

Source